Biotech Values

[RockRat]

You are aware Teva filed an ANDA for Integrilin with a paragraph IV challenge last January? It would be fun to get Teva's legal team to do the heavy lifting, then see Momenta beat it to market again. T'ain't exactly a blockbuster, though, about $300 million in sales.

http://shearlingsplowed.blogspot.com/2009/05/will-teva-market-generic-version-of.html

Notably, Teva will not get 180 day exclusivity should it prevail.

http://shearlingsplowed.blogspot.com/search/label/Integrilin%20Patent%20Teva%20Generic%20Suit%20April%2015%202010

Regards, RockRat